RE: ncyt27 Feb 2020 15:43
We are in a fantastic company here, this corona virus is not going away I have sold all stocks bar this one and my fave oiler that is just far too cheap and in at such a low.
I have done some further background reading on novacyt. Below are some little highlights
They are growing year on year - did £12m revenue last year (Will be so much higher this year and the next and next as viruses can more common)
Margins are getting better year on year
Cash in bank
Money before orders
Internationally recognised - Used worldwide by all majors
59 Distributors (was only 6 before the breakout would you believe)
And from their results (you can be sure the tests are being used globally)
Primerdesign completed a substantial q16 molecular instrument order, expanding the Group’s clinical diagnostic reach in the fast-growing Chinese market • New molecular CE Mark genesig® BKV Kit and genesig® EBV Kit assays were developed expanding the Group’s clinical diagnostic menu • Exclusive supply agreement signed by Primerdesign with US-based full-service diagnostic laboratory Genesis Diagnostics worth a minimum $3.0m over five years • Recently completed the rapid development of an African Swine Flu assay to help address the current swine flu food supply-chain limitations in China, Vietnam and certain European countries
My hunch imo - JV and I have a name in mind. There is no stopping this virus at the moment so surely it would make all the business sense in the world if you were say a Pfizer and already had a working relationship to approach the first CE and most reliable test provider (who is a minnow in terms of pharmas) and say hey why don't we help you, we will push/manufacture and take X. This would be far cheaper and quicker to get ahead of your rivals than the opportunity cost of doing nothing and loads of R&D.
Remember we are only 70m mcap currently it is not like we are multiple 100m